Calprotectin--a novel marker of obesity.
<h4>Background</h4>The two inflammatory molecules, S100A8 and S100A9, form a heterodimer, calprotectin. Plasma calprotectin levels are elevated in various inflammatory disorders. We hypothesized that plasma calprotectin levels would be increased in subjects with low-grade systemic inflam...
Guardado en:
Autores principales: | Ole Hartvig Mortensen, Anders Rinnov Nielsen, Christian Erikstrup, Peter Plomgaard, Christian Philip Fischer, Rikke Krogh-Madsen, Birgitte Lindegaard, Anne Marie Petersen, Sarah Taudorf, Bente Klarlund Pedersen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4414ab96a72494ab4f2a07471bfe9eb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Satellite cells derived from obese humans with type 2 diabetes and differentiated into myocytes in vitro exhibit abnormal response to IL-6.
por: Camilla Scheele, et al.
Publicado: (2012) -
Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV.
por: Birgitte Lindegaard, et al.
Publicado: (2013) -
Plasma and muscle myostatin in relation to type 2 diabetes.
por: Claus Brandt, et al.
Publicado: (2012) -
Changes in abdominal subcutaneous adipose tissue phenotype following menopause is associated with increased visceral fat mass
por: Julie Abildgaard, et al.
Publicado: (2021) -
Fecal calprotectin and microbiota of the gut
por: V. G. Gorokhova, et al.
Publicado: (2016)